Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001683168-24-007160
Filing Date
2024-10-15
Accepted
2024-10-15 17:24:04
Documents
3
Period of Report
2024-11-26

Document Format Files

Seq Description Document Type Size
1 FORM PRE 14A cns_pre14a.htm PRE 14A 186129
2 GRAPHIC proxy-1.jpg GRAPHIC 101307
3 GRAPHIC proxy-2.jpg GRAPHIC 167243
  Complete submission text file 0001683168-24-007160.txt   557286
Mailing Address 2100 WEST LOOP SOUTH SUITE 900 HOUSTON TX 77027
Business Address 2100 WEST LOOP SOUTH SUITE 900 HOUSTON TX 77027 1-800-946-9185
CNS Pharmaceuticals, Inc. (Filer) CIK: 0001729427 (see all company filings)

EIN.: 822318545 | State of Incorp.: NV | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-39126 | Film No.: 241372737
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)